Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 43.00
+0.90 (2.09%)
Mar 25, 2026, 3:46 PM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 49.79 million as of March 25, 2026. Its market cap has decreased by -74.14% in one year.
Market Cap
49.79M
Enterprise Value
60.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
43.00
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has decreased from 53.46M to 49.79M, a decrease of -6.87%. That is a compound annual growth rate of -0.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 49.79M | -75.83% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 119.34M |
| 4basebio | 78.93M |
| Bioventix | 73.67M |
| Hemogenyx Pharmaceuticals | 66.82M |
| Ondine Biomedical | 55.85M |
| hVIVO | 46.61M |
| Poolbeg Pharma | 29.44M |
| Arecor Therapeutics | 25.67M |